title: Primary cutaneous B-cell lymphoma: subtypes, treatment and outcome of 10 cases.
authors.forename: Nahide
authors.initials: N
authors.lastname: Onsun
authors.forename: Ozlem
authors.initials: O
authors.lastname: Su
authors.forename: Yasemin Balsever
authors.initials: YB
authors.lastname: Kural
authors.forename: Yeliz
authors.initials: Y
authors.lastname: Erdemoglu
authors.forename: Nesimi
authors.initials: N
authors.lastname: Buyukbabani
authors.forename: Cuyan
authors.initials: C
authors.lastname: Demirkesen
authors.forename: Yildiz
authors.initials: Y
authors.lastname: Aydin
mesh_terms: D005260:Female; D006801:Humans; D016393:Lymphoma, B-Cell / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000175:diagnosis / Q000628:therapy; D008224:Lymphoma, Follicular / Q000175:diagnosis / Q000628:therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome; D014421:Turkey